Pancreatic ductal adenocarcinoma: the latest on diagnosis, molecular profiling, and systemic treatments

Bugazia, Doaa; Al-Najjar, Ebtesam; Esmail, Abdullah; Abdelrahim, Saifudeen; Abboud, Karen; Abdelrahim, Adham; Umoru, Godsfavour; A. Rayyan, Hashem; Abudayyeh, Ala; Al Moustafa, Ala‐Eddin; Abdelrahim, Maen

doi:10.3389/fonc.2024.1386699

Public

Pancreatic ductal adenocarcinoma: the latest on diagnosis, molecular profiling, and systemic treatments

Published in Frontiers in Oncology • Jul 1, 2024

Authors:

Doaa Bugazia

Ebtesam Al-Najjar

Abdullah Esmail

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is currently the fourth leading cause of death in the United States and is expected to be ranked second in the next 10 years due to poor prognosis and a rising incidence. Distant metastatic PDAC is associated with the worst prognosis among the different phases...

Subject

Medicine

Pancreatic ductal adenocarcinoma

Oncology

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!